Effect of malignant tumor on neuromuscular block of cisatracurium
10.3760/cma.j.issn.0254-1416.2010.08.003
- VernacularTitle:恶性肿瘤对顺阿曲库铵肌松效应的影响
- Author:
Xuelian ZHAO
;
Yan GAO
;
Yuying XING
;
Qiao HUAI
;
Shijie WANG
- Publication Type:Journal Article
- Keywords:
Atracurium;
Neoplasms;
Neuromuscular blockade
- From:
Chinese Journal of Anesthesiology
2010;30(8):904-906
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of malignant tumor on neuromuscular block of cisatracurium. Methods Sixty ASA Ⅰ or Ⅱ patients with head and neck neoplasms (15 cases with benign tumor, 45 with malignant tumor), aged 18-64 yr, were randomly divided into 4 groups ( n = 15 each): Ⅰ benign tumor group (group B,3 × ED95 ); Ⅱ -Ⅳ different dose cisatracurium group (group C1 (2 × ED95 ), C2 (3 × ED95 ) and C3 (4 ×ED95)). Neuromuscular block was assessed with accelerograph F (TOF-watch SX). Single stimulation of ulnar nerve was used. Anesthesia was induced with TCI of propofol (target plasma concentration 3 μg/ml) and remifentanil (target effect-site concentration 3 ng/ml). Tracheal intubation was facilitated with cisatracurium 0.15 mg/kg in group B, and with cisatracurium 0.10, 0.15 and 0.20 mg/kg in group C1, C2 and C3 respectively. The onset time, clinical duration, time for recovery of T/Tc to 75 % and recovery index were recorded. Results The clinical duration, time for recovery of T/Tc to 75 % and recovery index were significantly longer in group C2 than in group B (P < 0.05). The onset time was significantly shorter, while the clinical duration and time for recovery of T/Tc to 75% were significantly longer in group C2 and C3 than in group C1 , and in group C3 than in group C2 ( P <0.05) .Conclusion The duration of action and recovery times of cisatracurium were prolonged in patients with malignant tumor.